Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, et al. A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma. Leuk Lymphoma. 2019;60(12):2917-2921.

Racine-Brzostek SE, Shi PA. Emerging roles of adjunct therapies in acquired thrombotic thrombocytopenia purpura. Transfusion. 2019;59(8):2496-2498.

Gomes AP, Ilter D, Low V, Rosenzweig A, Shen Z-, Schild T, et al. Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization. Cancer Cell. 2019;36(4):402-417.e13.

Nellis ME, Goel R, Karam O, Cushing MM, Davis PJ, Steiner ME, et al. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis. Pediatr Crit Care Med. 2019;20(7):e342-e351.

Randall EC, Zadra G, Chetta P, Lopez BG, Syamala S, Basu SS, et al. Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging. Mol Cancer Res. 2019;17(5):1155-1165.

Gaffney C, Golan R, Cantu MD, Scognamiglio T, McCarthy H, Mosquera JM, et al. The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer. J Urol. 2019;202(1):96-101.

Newman LA, Jenkins B, Chen Y, Oppong JK, Adjei E, Jibril AS, et al. Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative. Ann Surg. 2019;270(3):484-492.

Glynn S, Lipkin S, Zhang T, Sboner A, Elemento O, Van Besien K, et al. The application of precision medicine in diagnosing familial Mediterranean fever. Leuk Lymphoma. 2019;60(8):2091-2093.

McIntire PJ, Zhong E, Patel A, Khani F, D'Alfonso TM, Chen Z, et al. Hotspot enumeration of CD8+ tumor-infiltrating lymphocytes using digital image analysis in triple-negative breast cancer yields consistent results. Hum Pathol. 2019;85:27-32.

Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, et al. Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling. AJR Am J Roentgenol. 2019;212(4):883-891.